Regenerative Medicine

Summary

Science of regeneration offers huge opportunities for the betterment of mankind. Regenerative medicine offers therapeutic opportunities where there are presently no treatments. The regenerative medicine industry is in nascent stages in terms of commercial applications. To date, most of the advances made in regenerative medicine are confined to bone and joint applications, and to an extent regeneration of blood. Even in bone and joint applications the advances are limited to in-vitro development. Huge opportunity for regenerative medicine exists in in-vivo development. It would not be long before regenerative therapies for chronic conditions such as diabetes are realized.

These and other market data and trends are presented in "Regenerative Medicine: Global Market Trends" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Contents

• 1.Methodology
  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Quantitative Techniques & Reporting Level
• 2.Industry Overview
  • Regenerative Medicine - The past, The Present, & The Future
  • Another Revolution in The Making?
  • Conventional Chemical Medicine vs Regenerative Medicine
  • The Need for Regenerative Medicine
  • Regenerative Medicine Throws in Several New Therapies
  • What's in Store?
  • Regenerative Medicine to Arrest Ageing?
  • Thriving on An Aging World Population
  • Faster Healing Process
  • Regenerative Medicine to Overcome Donor Organs Shortage
  • Possible Scenarios
  • Stem Cell Research - Not Just Another Medical Advancement
  • Key Issues at Play
  • Market Potential
  • Regenerative Medicine in Bone and Joint Applications
  • US Corners A Lion's Share
  • Growth Drivers
  • Trends & Issues
  • Biomaterials Sought after in Regenerative Medicine
  • Upbeat Market for Cell-Based Tissue Engineering
  • Progenitor Cell Therapy to Witness No Holds Barred Growth
  • Players Embrace Automation in Production Facilities
  • Contract Manufacturing, A Growing Sector
  • Investors Wary of Funding Regenerative Medicine
  • Regenerative Medicine Field Lags behind Due to Segregated Focus
  • Challenges to Be Encountered by Tissue Engineering Companies
  • Activity in The Field of Regenerative Medicine
• 3.Products Facts
• 4.Regulatory Environment
  • Regulatory Norms Governing Es Cell Research
  • Legality of Es Cell Use in Major Developed Nations
• 5.Corporate Developments
  • Cytori and Green Hospital Supply Ink Strategic Equity Deal
  • Rnl Bio Establishes Research Unit at Newcastle University
  • Tengion Begins Third Phase Ii Clinical Trial of Neo-Bladder Augment/li>
  • Organogenesis Signs Mou with Ntec
  • Biotime Establishes New Stem Cell Division
  • Integra Life Sciences Acquires Isotis, Inc.
  • Novathera and Gamida Join Hands for Developing Cell Therapeutics for Lung- Regeneration
  • Tigenix Teams up with Fidea to Develop Biological Joint Implants
  • Scotland Plans to Build Center for Regenerative Medicine in Edinburgh
  • Celprogen Launches 11 Cancer Stem Cells
• 6.Major Players
  • Biovest International, Inc. (US)
  • Curis, Inc. (US)
  • Cytori Therapeutics, Inc. (US)
  • Develogen Ag (Germany)
  • Forticell Bioscience, Inc. (US)
  • Geron Corporation (US)
  • Human Genome Sciences, Inc. (US)
  • Isotis, Inc.
  • Kiadis Pharma B.V.
  • Lifecell Corporation (US)
  • Osiris Therapeutics, Inc. (US)
  • Tepha Inc. (US)
  • Tigenix N.V. (Belgium)
• 7.Global Market Analytics
• 8.The United States
  • Regenerative Medicine in Bone and Joint Applications
  • Regenerative Therapy - Best Fit for Joint Problems
  • Millions of American Patients Put Their Hope in Stem Cell Research
  • US Witnesses Mixed Response for Government Support for Hesc Research
  • Cbi's Human Tissue Products for Treating Liver Failure and Diabetes
  • Market for Liver and Pancreas Transplantation
  • Implantable Regenerative Products Take over Sports Medicine
• 9.Japan
  • Research Activity in Regenerative Medicine Field
  • More Companies Eye The Regenerative Medicine Potential
  • Competition Heats up behind Closed Doors
  • Japanese Firms Need to Catch up with US and European Competitors
  • Science Ministry Rolls out Regenerative Medicine Project
  • Regenerative Medicine Exempted from Ban on Human Cloning
• 10.Europe
• 11.Review of Regenerative Medicine in Other Geographic Markets
  • A.Canada
  • University of Toronto - Spearheading Regenerative Medicine Research
  • B.Asia-Pacific
  • China
  • Substantial Government Support
  • India
  • Csir- Leading The Way in Regenerative Medicine Research
  • High Growth Opportunities
  • South Korea
  • Malaysia
  • Singapore
  • C.Rest of World
  • Argentina
  • South Africa
• Exhibits
  • Table 1: Global Market for Regenerative Medicine Products in Bone and Joint Applications by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 2: Percentage Breakdown of Global Market for Regenerative Medicine Products for Bone and Joint Applications by Region for The Years 2008 &
  • Table 3: Prevalence of Various Diseases in The US
  • Table 4: The US Market for Regenerative Medicine Products in Bone and Joint Applications Market: 2007-2015 (Sales in US$ Million)
  • Table 5: Japanese Market for Regenerative Medicine Products in Bone and Joint Applications Market: 2007-2015 (Sales in US$ Million)
  • Table 6: European Market for Regenerative Medicine Products in Bone and Joint Applications Market: 2007-2015 (Sales in US$ Million)
• Companies Profiled